SB 61 (2007): relative to pharmaceutical marketers.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“SB 61 (2007): relative to pharmaceutical marketers.” Granite Record, https://graniterecord.org/bill/2007/sb61. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). SB 61 (2007): relative to pharmaceutical marketers. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2007/sb61
Chicago
Granite Record. “SB 61 (2007): relative to pharmaceutical marketers.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2007/sb61.
BibTeX
@misc{bill-2007-sb61, title = {SB 61 (2007): relative to pharmaceutical marketers.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2007/sb61}, note = {Accessed 24 Oct. 2026} }

SB 61 (2007)

relative to pharmaceutical marketers.

  • Status: Killed
  • Term: 2007-2008
  • Senate committee: Health and Human Services
  • Subject: Miscellaneous

The Story

It was introduced on January 4, 2007 and referred to the Senate Health and Human Services committee. The committee held a public hearing on March 27, 2007. The committee recommended that the Senate kill it. On April 12, 2007 the Senate voted to kill it on a roll call 16–7.

Sponsors

Hearings and Sessions

  • March 27, 2007, 11:00 AM: hearing, Senate Health and Human Services, SH 103

Votes

  • April 12, 2007, Senate: Inexpedient to Legislate Sen. Letourneau/Sen. Barnes — yeas 16, nays 7, passed

The Docket

  • January 4, 2007: Introduced and Referred to Health and Human Services
  • March 27, 2007: Hearing; === CANCELLED === March 27, 2007, Room 103, State House, 11:15 a.m.; SC12
  • March 27, 2007: Hearing; March 27, 2007, Room 103, State House 11:00 a.m.; SC13
  • April 5, 2007: Committee Report; Inexpedient to Legislate [04/12/07]; SC15
  • April 12, 2007: Inexpedient to Legislate RC 16Y-7N, MA

Related Bills

  • SB 211-FN (2006): relative to pharmaceutical marketers.
  • HB 703-FN (2006): relative to advertisement of prescription drugs and establishing the pharmaceutical marketing disclosure law.

From the General Court